C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof

Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2011
11/22/2011	US8063186 Antibodies to PRO7436 polypeptides
11/22/2011	US8062881 Method for making a polymer blend for reducing protein binding to surfaces
11/22/2011	CA2450572C Methods for purification of bacterial cells and cell components
11/17/2011	WO2011143562A2 Il-1 binding proteins
11/17/2011	WO2011140590A1 Binding systems
11/17/2011	US20110280910 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
11/17/2011	US20110280889 High affinity t cell receptor and use thereof
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	CA2799046A1 Il-1 binding proteins
11/16/2011	CN1820018B Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
11/16/2011	CN102241775A Purification method for polyethylene glycol thymus peptide 1 derivative
11/16/2011	CN102241741A Prion protein ligands and methods of use
11/16/2011	CN101638435B Blue-green algal virus protein N mutant, modified derivative and application thereof
11/15/2011	US8058411 Method for producing mature VWF from VWF pro-peptide
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058398 Modified G-CSF polypeptide
11/15/2011	US8058393 Microwave-assisted peptide synthesis
11/15/2011	US8058044 Deactivation of linking moieties in antibody-enzyme conjugates
11/15/2011	US8057892 Wood adhesive and method of preparing thereof
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/10/2011	WO2011138757A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/10/2011	WO2011138641A1 A construct comprising a ni and/or au substrate
11/10/2011	WO2011037896A4 Polypeptide modification
11/10/2011	US20110275788 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
11/10/2011	US20110275134 Arrestin Biosensor
11/10/2011	US20110275061 Assays using surface-enhanced raman spectroscopy (sers)-active particles
11/10/2011	US20110274713 Antigen-presenting scaffolds
11/09/2011	EP2385057A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/09/2011	EP1476182B1 Process for preparation of immunogenic formulations of variable peptidic epitopes
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053209 FRET protease assays for clostridial toxins
11/08/2011	US8053208 FRET protease assays for clostridial toxins
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/03/2011	US20110269665 Compound and method for treating myotonic dystrophy
11/03/2011	US20110268751 Weekly Dosing Regimens for Anti-CD30 VC-PAB-MMAE Antibody Drug-Conjugates
11/03/2011	US20110268744 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
11/02/2011	EP2383280A1 Expression system for toxic ion channels, in particular ryanodine receptors
11/02/2011	EP1501542B2 Improved polysaccharide and glycoconjugate vaccines
11/02/2011	EP1299522B1 Alteration of cell membrane
11/02/2011	CN101104078B Polypeptide and protein medicine polyethylene coupling compound
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same
10/2011
10/27/2011	US20110263502 Prodrugs and drug-macromolecule conjugates having controlled drug release rates
10/27/2011	US20110262964 Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use
10/27/2011	US20110262473 Synthetic vaccine component
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/26/2011	EP2380900A1 Isolation and use of ryanodine receptors
10/26/2011	EP2380899A1 Isolation and use of ryanodine receptors
10/26/2011	EP2380583A1 Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
10/26/2011	EP2379577A1 Compositions and methods for re-programming cells without genetic modification
10/26/2011	EP2269069B1 Use of synthetic peptide derived from zebra protein for the in vivo diagnosis of the epstein-barr virus (ebv) reactivation
10/26/2011	CN101845117B Preparation method of macro-porous protein molecular imprinting integral material
10/25/2011	US8044181 Antibodies to the PcrV antigen of Pseudomonas aeruginosa
10/25/2011	US8044180 FcγRIIB specific antibodies and methods of use thereof
10/25/2011	US8044178 Anti-5T4 antibodies and uses thereof
10/25/2011	US8044099 conjugates of a drug moiety and a pharmacokinetic modulating moiety, they exhibit at least one modulated pharmacokinetic property such as half-life, hepatic first-pass metabolism, volume of distribution and degree of blood protein binding, upon administering to a host
10/25/2011	US8044022 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
10/25/2011	US8044017 Ion exchange chromatography; gradient wash; resolution; remove impurities
10/25/2011	CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/20/2011	WO2011127585A1 Tumor cell-derived microvesicles
10/20/2011	US20110256552 Method for preparing a substrate for immobilizing a cell, said substrate and uses thereof
10/20/2011	US20110256550 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256543 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
10/20/2011	US20110256303 Process for crosslinking proteins with dihydroxyacetone
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256157 Pyrrolobenzodiazepines and conjugates thereof
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	CA2796277A1 Tumor cell-derived microvesicles
10/19/2011	EP2377876A1 Use of proteins and peptides of the TGF-BETA superfamily for purification and therapeutic methods
10/19/2011	EP2376110A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
10/18/2011	US8039597 Antibodies and related molecules that bind to 24P4C12 proteins
10/18/2011	US8039592 Optimized Fc variants and methods for their generation
10/18/2011	US8039590 Heteromeric taste receptors comprising T1R2/T1R3 domains
10/18/2011	US8039585 for use in treatment and prevention of vision defects and cell proliferative disorders
10/18/2011	US8039582 Peptide networks
10/18/2011	US8039273 Antibodies; anticancer agents; autoimmune disorders
10/18/2011	US8039003 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
10/18/2011	US8039000 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
10/18/2011	CA2456286C Porous matrix comprising cross-linked particles
10/13/2011	US20110250146 Magnetic nanoparticle and method for imaging t cells
10/12/2011	EP2373693A1 Compositions and methods for the treatment or the prevention oral infections by e. coli
10/12/2011	EP1853915B1 Method for detecting misfolded proteins and prions
10/12/2011	EP1534755B1 Generation of surface coating diversity
10/12/2011	CN102212019A Branched water-soluble polymers and their conjugates
10/12/2011	CN102210872A Polyethylene glycol modified peptide pharmaceutical formulation and preparation method thereof
10/11/2011	US8034897 Recombinant spider silk proteins
10/11/2011	US8034785 Adsorbent adsorbing antibody against β1 adrenoreceptor
10/11/2011	US8034781 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/11/2011	US8034776 Orallyl administering a zonulin antagonist comprising an octapeptide; monitoring; administering a gluten challenge; diagnosis of celiac disease by determining amount of interferons, interleukins, or nitrates in a sample and evaluating
10/11/2011	US8034762 Treatment of subarachnoid hemorrhage with Apo E analogs
10/11/2011	CA2458462C Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/04/2011	US8030468 Human T2R51 taste receptor nucleic acid sequences and polypeptides
10/04/2011	US8030451 Isolated bitter taste receptor polypeptides
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides

1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 107